Amyloid beta oligomers, which are known to accumulate along AD progression have been reported to interfere with insulin receptor activity [72]; insulin receptor dysfunctions could also be, in turn, responsible for the impairments of oligomer clearance. This evidence concerns the gene INSR and Alzheimer disease.